Company page
Xortx Therapeutics, Inc.
Xortx Therapeutics, Inc. is a publicly traded company on the Canadian market under the ticker XRTX. The company has a market capitalization of approximately CAD 3.71 million. Xortx focuses on developing innovative therapies for kidney-related conditions.
- Ticker
- XRTX:TSXV
- Asset type
- Stock
- Market cap
- $3.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSXV
- Currency
- CAD